Integrating DNA methylation measures to improve clinical risk assessment are we there yet The case of BRCA1Âmethylation marks to improve clinical risk assessment of breast cancer

Integrating DNA methylation measures to improve clinical risk assessment: are we there yet? The case of BRCA1 methylation marks to improve clinical risk assessment of breast cancer

15:42 EST 18 Feb 2020 | Nature Publishing

More From BioPortfolio on "Integrating DNA methylation measures to improve clinical risk assessment: are we there yet? The case of BRCA1 methylation marks to improve clinical risk assessment of breast cancer"